{"transactions":[{"id":1821324,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T10:08:20.000Z","date":"2023-07-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"Vests on the earlier of July 27, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service."}],"balance_after":101459,"source":{"system":"sec-edgar","filing":"0001104659-23-084965","document":"tm2321997-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465923084965/tm2321997-6_4seq1.xml","form_type":"4"}},{"id":1821323,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T10:08:20.000Z","date":"2023-07-27","kind":"grant","planned":false,"acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"50% of the RSUs vested immediately, and the remainder will vest in two equal installments on each subsequent anniversary of the date of grant, subject to continuing service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The share amount has been adjusted to reflect the reverse stock split effective on September 12, 2022 whereby each thirty shares issued and outstanding prior to the split were combined and converted into one share of common stock."}],"balance_after":88959,"source":{"system":"sec-edgar","filing":"0001104659-23-084965","document":"tm2321997-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465923084965/tm2321997-6_4seq1.xml","form_type":"4"}},{"id":1821322,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T10:02:13.000Z","date":"2022-07-26","kind":"other","planned":false,"acquired":true,"shares":4671,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by E&Investment Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment is being filed to add the acquisition of 4,671 shares by E&Investment Inc., which was inadvertently left off the original Form 4."},{"field":"kind","element":"transactionCoding","label":"F2","text":"E&Investment Inc. received a pro rata distribution from E&Healthcare Investment Fund II, of which the reporting person is a limited partner, for no consideration."},{"field":"shares","element":"transactionShares","label":"F3","text":"The share amount has been adjusted to reflect the reverse stock split effective on September 12, 2022 whereby each thirty shares issued and outstanding prior to the split were combined and converted into one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The share amount has been adjusted to reflect the reverse stock split effective on September 12, 2022 whereby each thirty shares issued and outstanding prior to the split were combined and converted into one share of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Ms. Kim is the Chief Executive Officer of E&Investment, Inc., which is the sole general partner of The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7, and as such, has voting and investment control over the shares held by E&Investment and its affiliated funds. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein."}],"balance_after":4671,"source":{"system":"sec-edgar","filing":"0001104659-23-084928","document":"tm2321997-7_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465923084928/tm2321997-7_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-07-28"}},{"id":2200727,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-28T20:03:55.000Z","date":"2022-07-26","kind":"other","acquired":false,"shares":1445267,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by The E&Healthcare Investment Fund II"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Ms. Kim is the Chief Executive Officer of E&Investment, Inc., which is the sole general partner of The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7, and as such, has voting and investment control over the shares held by E&Investment and its affiliated funds. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein."}],"balance_after":2890533,"source":{"system":"sec-edgar","filing":"0001104659-22-083645","document":"tm2222080-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465922083645/tm2222080-1_4seq1.xml","form_type":"4"}},{"id":2233644,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2022-06-13T20:14:32.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of June 9, 2023 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service."}],"balance_after":20000,"derivative":{"exercise_price":0.4725,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-070532","document":"tm2218193-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000110465922070532/tm2218193-6_4seq1.xml","form_type":"4"}},{"id":3310525,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-qualified stock option (right to buy)","published_at":"2020-01-16T00:13:59.000Z","date":"2020-01-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments beginning on 2/13/2020, such that the option will be fully vested on the third anniversary of the date of grant."}],"balance_after":60000,"derivative":{"exercise_price":8.39,"expiration_date":"2030-01-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001683168-20-000161","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000161/ownership.xml","form_type":"4"}},{"id":3326612,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T02:52:12.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":1864799,"ownership":{"direct":false,"nature":"Held by The E&Healthcare Investment Fund No. 7"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in connection with the closing of the Merger in exchange for 1,500,000 shares of common stock issued upon the conversion of Series B preferred stock of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, and 131,353 shares of common stock issued upon conversion of convertible promissory notes of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by The E&Healthcare Investment Fund No. 7."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing of the Merger, each share of NeuroBo common stock was exchanged for 1.1431 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Ms. Kim is the Chief Executive Officer of E&I Investment. E&Investment is the sole general partner of The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7, and has voting power over the shares held by The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7. Ms. Kim is the Chief Executive Officer of E&Investment, and as such has voting and investment control over the shares held by E&Investment and its affiliated funds. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein."}],"balance_after":1864799,"source":{"system":"sec-edgar","filing":"0001683168-20-000014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000014/ownership.xml","form_type":"4"}},{"id":3326611,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T02:52:12.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":1121190,"ownership":{"direct":false,"nature":"Held by The E&Healthcare Investment Fund No. 6"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in connection with the closing of the Merger in exchange for 900,000 shares of common stock issued upon conversion of Series B preferred stock of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, and 80,833 shares of common stock issued upon conversion of convertible promissory notes of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by The E&Healthcare Investment Fund No. 6."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing of the Merger, each share of NeuroBo common stock was exchanged for 1.1431 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Ms. Kim is the Chief Executive Officer of E&I Investment. E&Investment is the sole general partner of The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7, and has voting power over the shares held by The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7. Ms. Kim is the Chief Executive Officer of E&Investment, and as such has voting and investment control over the shares held by E&Investment and its affiliated funds. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein."}],"balance_after":1121190,"source":{"system":"sec-edgar","filing":"0001683168-20-000014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000014/ownership.xml","form_type":"4"}},{"id":3326610,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":111050,"kind":"person","name":"Kim Na Yeon","position":1,"cik":"0001794779","reported_name":"Kim Na Yeon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-03T02:52:12.000Z","date":"2019-12-30","kind":"grant","acquired":true,"shares":4335800,"ownership":{"direct":false,"nature":"Held by The E&Healthcare Investment Fund II"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in connection with the closing of the merger of GR Merger Sub Inc., a wholly-owned subsidiary of the Issuer, with and into NeuroBo Therapeutics, Inc. (formerly NeuroBo Pharmaceuticals, Inc.) (\"NeuroBo\") on December 30, 2019 (the \"Merger\"), in exchange for 3,500,000 shares of common stock issued upon the conversion of Series A preferred stock of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, and 293,019 shares of common stock issued upon conversion of convertible promissory notes of NeuroBo, which conversion occurred immediately prior to the closing of the Merger, held by The E&Healthcare Investment Fund II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the closing of the Merger, each share of NeuroBo common stock was exchanged for 1.1431 shares of the Issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Ms. Kim is the Chief Executive Officer of E&I Investment. E&Investment is the sole general partner of The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7, and has voting power over the shares held by The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6 and The E&Investment Healthcare Fund No. 7. Ms. Kim is the Chief Executive Officer of E&Investment, and as such has voting and investment control over the shares held by E&Investment and its affiliated funds. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein."}],"balance_after":4335800,"source":{"system":"sec-edgar","filing":"0001683168-20-000014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638287/000168316820000014/ownership.xml","form_type":"4"}}]}